In this study , we evaluated the clinical relevance of serum drug levels and antidrug antibodies ( ADAbs ) with regard to response to treatment , as well as to relapse upon treatment discontinuation , in peripheral spondyloarthritis ( pSpA ) patients treated with adalimumab .